novo nordisk glp-1 medications GoodRx, team to make meds affordable EMA will monitor suicide risk

Abstract Alzheimers disease (AD) is the most prevalent cause of dementia worldwide, disproportionately affecting women and lacking effective disease-modifying therapies

Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis

A clinical trial of once-weekly TZT in T2DM patients illustrated that at 26 weeks of treatment, TZT led to the significant reduction of intercellular adhesion molecule 1 (ICAM-1), growth differentiation factor 15 (GDF-15), chitosan-3 like protein 1 (YKL-40), leptin and CRP compared to the baseline values

GLP-1 medications, often referred to as GLP-1 agonists, are a type of medications that help manage blood sugar levels in people with Type 2 diabetes, and they are also used to treat obesity